Annual Current Assets
$61.89 M
-$9.19 M-12.93%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual total current assets is $61.89 million, with the most recent change of -$9.19 million (-12.93%) on June 30, 2024.
- During the last 3 years, AYTU annual current assets has fallen by -$43.34 million (-41.19%).
- AYTU annual current assets is now -41.19% below its all-time high of $105.23 million, reached on June 30, 2021.
Performance
AYTU Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$60.74 M
-$1.15 M-1.86%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly total current assets is $60.74 million, with the most recent change of -$1.15 million (-1.86%) on September 30, 2024.
- Over the past year, AYTU quarterly current assets has dropped by -$9.86 million (-13.97%).
- AYTU quarterly current assets is now -42.28% below its all-time high of $105.23 million, reached on June 30, 2021.
Performance
AYTU Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AYTU Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.9% | -14.0% |
| 3 y3 years | -41.2% | -31.8% |
| 5 y5 years | +301.0% | -39.3% |
AYTU Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.2% | +3.3% | -30.6% | +1.4% |
| 5 y | 5-year | -41.2% | +301.0% | -42.3% | +231.2% |
| alltime | all time | -41.2% | >+9999.0% | -42.3% | >+9999.0% |
Aytu BioPharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $60.74 M(-1.9%) |
| Jun 2024 | $56.20 M(-14.0%) | $61.89 M(-13.0%) |
| Mar 2024 | - | $71.13 M(-0.3%) |
| Dec 2023 | - | $71.37 M(+1.1%) |
| Sep 2023 | - | $70.60 M(-0.7%) |
| Jun 2023 | $65.38 M(-15.8%) | $71.08 M(-9.4%) |
| Mar 2023 | - | $78.47 M(+11.1%) |
| Dec 2022 | - | $70.61 M(-5.1%) |
| Sep 2022 | - | $74.42 M(+24.2%) |
| Jun 2022 | $77.69 M(-51.6%) | $59.93 M(-23.1%) |
| Mar 2022 | - | $77.95 M(-11.0%) |
| Dec 2021 | - | $87.54 M(-1.7%) |
| Sep 2021 | - | $89.04 M(-15.4%) |
| Jun 2021 | $160.43 M(+106.0%) | $105.23 M(+5.2%) |
| Mar 2021 | - | $100.01 M(+8.1%) |
| Dec 2020 | - | $92.54 M(+41.4%) |
| Sep 2020 | - | $65.45 M(-13.2%) |
| Jun 2020 | $77.87 M(+303.7%) | $75.42 M(-9.4%) |
| Mar 2020 | - | $83.25 M(+354.0%) |
| Dec 2019 | - | $18.34 M(+53.0%) |
| Sep 2019 | - | $11.98 M(-22.4%) |
| Jun 2019 | $19.29 M(+66.4%) | $15.43 M(-16.4%) |
| Mar 2019 | - | $18.46 M(-16.0%) |
| Dec 2018 | - | $21.98 M(+219.8%) |
| Sep 2018 | - | $6.87 M(-27.4%) |
| Jun 2018 | $11.59 M(-3.2%) | $9.47 M(-35.1%) |
| Mar 2018 | - | $14.60 M(+88.5%) |
| Dec 2017 | - | $7.74 M(-20.5%) |
| Sep 2017 | - | $9.74 M(+221.7%) |
| Jun 2017 | $11.97 M(-15.8%) | $3.03 M(-31.8%) |
| Mar 2017 | - | $4.44 M(-45.6%) |
| Dec 2016 | - | $8.16 M(+28.2%) |
| Sep 2016 | - | $6.36 M(-37.1%) |
| Jun 2016 | $14.22 M | $10.12 M(-3.0%) |
| Mar 2016 | - | $10.44 M(-18.2%) |
| Dec 2015 | - | $12.76 M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $11.31 M(+40.6%) |
| Jun 2015 | $10.14 M(>+9900.0%) | $8.04 M(+387.3%) |
| Mar 2015 | - | $1.65 M(>+9900.0%) |
| Feb 2015 | - | $7100.00(-23.7%) |
| Nov 2014 | - | $9300.00(+272.0%) |
| Aug 2014 | $3000.00(-100.0%) | $2500.00(-73.1%) |
| Jun 2014 | $8.71 M(>+9900.0%) | - |
| May 2014 | - | $9300.00(+4550.0%) |
| Feb 2014 | - | $200.00(-66.7%) |
| Nov 2013 | - | $600.00(-68.4%) |
| Aug 2013 | $7800.00(-37.6%) | $1900.00(+171.4%) |
| May 2013 | - | $700.00(-78.1%) |
| Feb 2013 | - | $3200.00(+357.1%) |
| Nov 2012 | - | $700.00(+250.0%) |
| Aug 2012 | $12.50 K(-32.8%) | $200.00(0.0%) |
| May 2012 | - | $200.00(-80.0%) |
| Feb 2012 | - | $1000.00(-47.4%) |
| Nov 2011 | - | $1900.00(-54.8%) |
| Aug 2011 | $18.60 K(-26.8%) | $4200.00(-48.8%) |
| May 2011 | - | $8200.00(+28.1%) |
| Feb 2011 | - | $6400.00(+481.8%) |
| Nov 2010 | - | $1100.00(-35.3%) |
| Aug 2010 | $25.40 K(-9.3%) | $1700.00(-79.5%) |
| May 2010 | - | $8300.00(+1283.3%) |
| Feb 2010 | - | $600.00(-83.8%) |
| Nov 2009 | - | $3700.00(-73.4%) |
| Aug 2009 | $28.00 K(-22.9%) | $13.90 K(+6.9%) |
| May 2009 | - | $13.00 K(+25.0%) |
| Feb 2009 | - | $10.40 K(-43.5%) |
| Nov 2008 | - | $18.40 K(-51.3%) |
| Aug 2008 | $36.30 K(0.0%) | $37.80 K(-13.7%) |
| May 2008 | - | $43.80 K(-24.7%) |
| Feb 2008 | - | $58.20 K(-15.9%) |
| Nov 2007 | - | $69.20 K(+195.7%) |
| Aug 2007 | $36.30 K | $23.40 K(-21.2%) |
| May 2007 | - | $29.70 K |
FAQ
- What is Aytu BioPharma annual total current assets?
- What is the all time high annual current assets for Aytu BioPharma?
- What is Aytu BioPharma annual current assets year-on-year change?
- What is Aytu BioPharma quarterly total current assets?
- What is the all time high quarterly current assets for Aytu BioPharma?
- What is Aytu BioPharma quarterly current assets year-on-year change?
What is Aytu BioPharma annual total current assets?
The current annual current assets of AYTU is $61.89 M
What is the all time high annual current assets for Aytu BioPharma?
Aytu BioPharma all-time high annual total current assets is $105.23 M
What is Aytu BioPharma annual current assets year-on-year change?
Over the past year, AYTU annual total current assets has changed by -$9.19 M (-12.93%)
What is Aytu BioPharma quarterly total current assets?
The current quarterly current assets of AYTU is $60.74 M
What is the all time high quarterly current assets for Aytu BioPharma?
Aytu BioPharma all-time high quarterly total current assets is $105.23 M
What is Aytu BioPharma quarterly current assets year-on-year change?
Over the past year, AYTU quarterly total current assets has changed by -$9.86 M (-13.97%)